Inhibrx Biosciences, Inc. INBX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 6.5×+1.3× | 3.9×0.0× | 4.5×-0.2× | 5×-1.2× | 5.1×— | |
| Per Share | ||||||
| Book value per share | -$1.35-122% | $0.52-94.2% | $2.38-79.4% | $4.43-70.1% | $6.11+620% | |
| Valuation | ||||||
| Market capitalization | $982.03M+385% | $1.15B+415% | $487.87M+115% | $213.66M+4.2% | $202.52M-60.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Inhibrx Biosciences, Inc.'s ratios come from?
- Every ratio is computed from Inhibrx Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
